The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Alternatives to Incarceration for Drug‐Related Offenses
Alternatives to incarceration (ATIs) are mainly designed for offenders whose criminal behavior is driven by an underlying substance abuse disorder. This behavior can include not only crimes related to substance use (e.g., possession) but...
Building Inclusive Recovery Cities: An international movement for community building, recovery and prevention.
ISSUP, in collaboration with the Centre for Addiction Recovery Research (CARR), presents its webinar on Building Inclusive Recovery Cities. This webinar combines key innovations in public-facing recovery programmes that challenge stigma and...
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
Background: Limited research has been conducted on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study provided an opportunity to investigate the prevalence of...
People who use drugs engagement in substance use disorder services and harm reduction: evaluation, challenges and future direction of a community-based intervention
Background: Since 1996, an urban community-based organization has been providing screening, testing, overdose prevention, referrals, and access to treatment for substance use disorders (SUD) and communicable diseases such as HIV through its...
A qualitative study of experiences with physical activity among people receiving opioid agonist therapy
Background: Many people with substance use disorders undergoing opioid agonist therapy often have physical or mental health commorbidities. Exercise is recognised as beneficial for both prevention and treatment of various health conditions...
Prevention Plus Wellness Programs Include SBIRT Protocol
Prevention Plus Wellness (PPW) programs, like the SPORT, Marijuana, Vaping, Opioid and InShape PPW programs for adolescents and young adults include materials and directions for implementation as an optional Screening, Brief Intervention...
Substance Use Disorder Trajectories and Outcomes Within the Broader Socio-Environmental Context: An NIH HEAL Initiative Workshop
Dates:
Wed, 5/15/2024 - 12:00pm - 5:00pm
Mon, 5/20/2024 - 12:00pm - 5:00pm
Toxicological Aspects of the Electronic Cigarette
ISSUP Colombia presents its webinar on “Toxicological Aspects of Electronic Cigarettes”.
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.
Looking Back: A retirement interview with Jeff Lee
Jeff Lee is well known in the field of drug demand reduction and is a founding figure in the creation of ISSUP. For over four decades, Jeff has played a major role in drug prevention and has undertaken and managed projects in more than 80 countries around the world. Jeff finally retired in March from his role as a Senior Consultant for ISSUP. In a quick chat with Jeff, he offers us a glimpse into his successful career, lessons learned, upcoming adventures and hopes for the future.